These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17932757)

  • 1. Comparing resource utilization and gastrointestinal outcomes in patients treated with either standard-dose or high-dose proton pump inhibitors: a matched cohort study.
    Targownik LE; Metge C; Leung S
    Dig Dis Sci; 2008 Jun; 53(6):1519-26. PubMed ID: 17932757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost Effectiveness of Gastroprotection with Proton Pump Inhibitors in Older Low-Dose Acetylsalicylic Acid Users in the Netherlands.
    Chau SH; Sluiter RL; Kievit W; Wensing M; Teichert M; Hugtenburg JG
    Drugs Aging; 2017 May; 34(5):375-386. PubMed ID: 28361278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
    Targownik LE; Metge CJ; Leung S; Chateau DG
    Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
    Lassalle M; Le Tri T; Bardou M; Biour M; Kirchgesner J; Rouby F; Dumarcet N; Zureik M; Dray-Spira R
    Eur J Clin Pharmacol; 2020 Mar; 76(3):449-457. PubMed ID: 31838548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
    Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
    Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Validity of proton pump inhibitors' prescriptions in a department of internal medicine].
    Marie I; Moutot A; Tharrasse A; Hellot MF; Robaday S; Hervé F; Lévesque H
    Rev Med Interne; 2007 Feb; 28(2):86-93. PubMed ID: 17092611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs.
    Sturkenboom MC; Burke TA; Tangelder MJ; Dieleman JP; Walton S; Goldstein JL
    Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1137-47. PubMed ID: 14653834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
    Luo H; Fan Q; Xiao S; Chen K
    BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of proton pump inhibitors and mortality after hip fracture in a nationwide study.
    Brozek W; Reichardt B; Zwerina J; Dimai HP; Klaushofer K; Zwettler E
    Osteoporos Int; 2017 May; 28(5):1587-1595. PubMed ID: 28083667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction.
    Sehested TSG; Carlson N; Hansen PW; Gerds TA; Charlot MG; Torp-Pedersen C; Køber L; Gislason GH; Hlatky MA; Fosbøl EL
    Eur Heart J; 2019 Jun; 40(24):1963-1970. PubMed ID: 30851041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-prescribing of proton pump inhibitors among chronic users of NSAIDs in the UK.
    Suh DC; Hunsche E; Shin HC; Mavros P
    Rheumatology (Oxford); 2008 Apr; 47(4):458-63. PubMed ID: 18263598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in prescribing proton pump inhibitors in Taiwan: 1997 - 2000.
    Chen TJ; Chou LF; Hwang SJ
    Int J Clin Pharmacol Ther; 2003 May; 41(5):207-12. PubMed ID: 12776811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumer use of over-the-counter proton pump inhibitors in patients with gastroesophageal reflux disease.
    Sheikh I; Waghray A; Waghray N; Dong C; Wolfe MM
    Am J Gastroenterol; 2014 Jun; 109(6):789-94. PubMed ID: 24896751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resource.
    Pollock K; Grime J
    Soc Sci Med; 2000 Dec; 51(12):1827-39. PubMed ID: 11128270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.
    Lazzaroni M; Porro GB
    Drugs; 2009; 69(1):51-69. PubMed ID: 19192936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitor co-prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar.
    Awaisu A; Hamou F; Mekideche L; El Muabby N; Mahfouz A; Mohammed S; Saad A
    Int J Clin Pharm; 2016 Apr; 38(2):353-61. PubMed ID: 26749343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study.
    Kelly OB; Dillane C; Patchett SE; Harewood GC; Murray FE
    Dig Dis Sci; 2015 Aug; 60(8):2280-6. PubMed ID: 25840918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing proton pump inhibitors for initial treatment of acid-related gastrointestinal diseases in a managed care population.
    Chan J; Hui RL; Szpakowski JL
    Am J Manag Care; 2004 Jul; 10(7 Pt 1):433-41. PubMed ID: 15298365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.